Standard Contracts
AGREEMENT ---------Credit Agreement • April 13th, 2000 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledApril 13th, 2000 Company Industry Jurisdiction
NOTE ---- PURCHASE AGREEMENT ------------------Note Purchase Agreement • March 23rd, 1998 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledMarch 23rd, 1998 Company Industry Jurisdiction
Exhibit 99.2 ------------ Form of Non-Qualified Stock Option Agreement -------------------------------------------- SYNBIOTICS CORPORATION NON- QUALIFIED STOCK OPTION AGREEMENT THIS AGREEMENT, entered into as of the 7th day of March, 1998, is by and...Non-Qualified Stock Option Agreement • March 1st, 1999 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledMarch 1st, 1999 Company Industry Jurisdiction
ARTICLE III ARTICLES OF INCORPORATION AND BYLAWSMerger Agreement • March 23rd, 1998 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledMarch 23rd, 1998 Company Industry
Section 1. Certain Definitions............................................ 1 Section 2. Appointment of Rights Agent.................................... 5 Section 3. Issue of Rights Certificate.................................... 6 Section 4. Form of...Rights Agreement • October 7th, 1998 • Synbiotics Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 7th, 1998 Company Industry Jurisdiction
ARTICLE I DEFINITIONSSecurity Agreement • November 14th, 2000 • Synbiotics Corp • In vitro & in vivo diagnostic substances • Maryland
Contract Type FiledNovember 14th, 2000 Company Industry Jurisdiction
2.1. General; Warrant Price................................ 3 2.2. Adjustment of Warrant Price........................... 4 2.2.1 Issuance of Additional Shares of Common Stock................................. 4 2.2.2 Extraordinary Dividends and...Common Stock Purchase Warrant • November 14th, 1997 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledNovember 14th, 1997 Company Industry Jurisdiction
ARTICLE I - DEFINITIONS ----------------------- For purposes of this Agreement the words and phrases set forth in this Article shall have the following meanings:Settlement Agreement • November 16th, 1998 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledNovember 16th, 1998 Company Industry
EXHIBIT 2.5 ----------- STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 24th, 1997 • Synbiotics Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJuly 24th, 1997 Company Industry Jurisdiction
AGREEMENT ---------Credit Agreement • May 14th, 1999 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledMay 14th, 1999 Company Industry Jurisdiction
ARTICLE I THE EXCHANGE ------------Exchange Agreement • May 22nd, 2000 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledMay 22nd, 2000 Company Industry Jurisdiction
ARTICLE I DEFINITIONSSupply Agreement • May 14th, 1997 • Synbiotics Corp • In vitro & in vivo diagnostic substances • New Jersey
Contract Type FiledMay 14th, 1997 Company Industry Jurisdiction
ASSIGNMENT AGREEMENTAssignment Agreement • April 1st, 2002 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledApril 1st, 2002 Company IndustryThis Assignment Agreement (this "Agreement") is made and entered into as of October 29, 2001 (the "Effective Date") by and between Agen Biomedical Limited, an Australian company, having its principal place of business at 11 Durbell Street, Acacia Ridge, Queensland 4110, Australia ("Agen"), and Synbiotics Corporation, a California corporation, having its principal place of business at 11011 Via Frontera, San Diego, CA 92127, United States of America ("Synbiotics").
ARTICLE 1 --------- TERM OF AGREEMENT -----------------Employment Agreement • August 14th, 2001 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledAugust 14th, 2001 Company Industry Jurisdiction
FIRST AMENDMENT This Amendment is incorporated in and made a part of that certain lease dated November 1, 1996, between Bernardo View Ltd., the Lessor and Synbiotics Corporation, the Lessee. The following represents the Amendment: 1) Tenant...Lease Amendment • November 14th, 2000 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledNovember 14th, 2000 Company Industry
BY AND BETWEENAsset Purchase Agreement • November 14th, 2000 • Synbiotics Corp • In vitro & in vivo diagnostic substances • Maryland
Contract Type FiledNovember 14th, 2000 Company Industry Jurisdiction
RECITALS --------Non-Competition Agreement • May 22nd, 2000 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledMay 22nd, 2000 Company Industry Jurisdiction
BACKGROUNDLicense Agreement • May 14th, 1997 • Synbiotics Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 14th, 1997 Company Industry Jurisdiction
ARTICLE 1 --------- TERM OF AGREEMENT -----------------Employment Agreement • May 15th, 1998 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledMay 15th, 1998 Company Industry Jurisdiction
ARTICLE I --------- TERM OF AGREEMENT -----------------Employment Agreement • May 14th, 1997 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledMay 14th, 1997 Company Industry Jurisdiction
AMENDMENT OF EMPLOYMENT CONTRACTEmployment Contract • August 14th, 2001 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledAugust 14th, 2001 Company IndustryThe Employment Contract dated October 12, 1997 between Francois Guillemin and Synbiotics Europe SAS/Synbiotics Corporation (the "Contract") is hereby amended as follows. The purpose of these revisions is to assure that, if Mr. Guillemin has the opportunity to keep his position with an Acquirer of the assets of Synbiotics, this would be considered a continuation of his employment and not a termination by Synbiotics.
AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 22nd, 1997 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledSeptember 22nd, 1997 Company Industry
EXHIBIT 10.64 ------------- CREDIT AGREEMENTCredit Agreement • July 24th, 1997 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledJuly 24th, 1997 Company Industry Jurisdiction
Exhibit 2.10 ------------ STOCK PURCHASE AGREEMENT This Stock Purchase Agreement is made at the close of business on December 31, 2000 among Synbiotics Corporation, a California corporation ("Synbiotics"), W3COMMERCE inc., a Delaware corporation...Stock Purchase Agreement • January 16th, 2001 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledJanuary 16th, 2001 Company Industry Jurisdiction
AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 22nd, 1997 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledSeptember 22nd, 1997 Company Industry
EXHIBIT 10.38.1 --------------- ADDENDUM To DISTRIBUTION AGREEMENTDistribution Agreement • November 14th, 1996 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledNovember 14th, 1996 Company Industry
AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENTStock Purchase Agreement • September 22nd, 1997 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledSeptember 22nd, 1997 Company Industry
PROMISSORY NOTE ---------------Promissory Note • February 7th, 2002 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 7th, 2002 Company Industry
RECITALSLease Agreement • May 4th, 2001 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledMay 4th, 2001 Company Industry
EXHIBIT 2.4 ----------- ASSET PURCHASE AGREEMENTAsset Purchase Agreement • July 24th, 1997 • Synbiotics Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJuly 24th, 1997 Company Industry Jurisdiction
FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • August 14th, 2000 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledAugust 14th, 2000 Company Industry
EXHIBIT 10.52 ------------- CONTRACT MANUFACTURING AGREEMENT This Agreement is entered into on this 31st day of March, 1995 by and between [*], an [*] corporation [*] and SYNBIOTICS CORPORATION, 11011 Via Frontera, San Diego, CA 92127-1702, a...Contract Manufacturing Agreement • March 29th, 1996 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledMarch 29th, 1996 Company Industry Jurisdiction
AGREEMENT ---------Credit Agreement • February 7th, 2002 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledFebruary 7th, 2002 Company Industry Jurisdiction
EXHIBIT 10.41.1 --------------- ADDENDUM TO AGREEMENT The Agreement between Rhone Merieux, Inc. ("RMI") and Synbiotics ("Synbiotics") dated January 1, 1992 (the "Agreement"), is amended as follows: 1.0 Effective immediately, Synbiotics shall have...Addendum to Agreement • November 14th, 1996 • Synbiotics Corp • In vitro & in vivo diagnostic substances
Contract Type FiledNovember 14th, 1996 Company Industry
Exhibit 10.74.2 --------------- INTERCREDITOR AGREEMENT THIS INTERCREDITOR AGREEMENT is entered into as of April 18, 2000, by and among IMPERIAL BANK, a California banking company (the "Bank"), SYNBIOTICS CORPORATION, a California corporation,...Intercreditor Agreement • November 14th, 2000 • Synbiotics Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledNovember 14th, 2000 Company Industry Jurisdiction